This was in keeping with a previous report where different stages of albuminuria showed different levels of ANGPTL8, whereby ANGPTL8 was suggested as a novel regulator in developing DN [18,43] and a novel predictive risk marker for all-cause mortality in people with T2D [17]. Here, ANGPTL8 is linked to liver dysplastic nodule.